TrialBritish journal of haematology2020

Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial.

Jeanette K Doorduijn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.